Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - hexazinone - soluble concentrate - hexazinone triazine-triazinones active 250.0 g/l - herbicide

Estados Unidos - inglês - NLM (National Library of Medicine)

greer laboratories, inc. - sporisorium cruentum (unii: gqm6lvu5v8) (sporisorium cruentum - unii:gqm6lvu5v8) - allergenic extracts are indicated for the diagnosis and treatment of patients with immediate hypersensitivity allergy to the respective allergens, inhaled, ingested or otherwise introduced into contact with sensitive tissues. the diagnosis of ige‑mediated allergy may be established by the allergy history, clinical evaluation, and skin test reactivity. (4,7,11) immunotherapy with allergenic extracts is indicated when testing and patient history have identified the offending allergens and when it is not possible or practical to avoid these allergens. (12‑14) food extracts have not been proven effective in immunotherapy. the use of allergenic extracts for the above purposes should be made only by physicians with special familiarity and knowledge of allergy. (see dosage and administration) there are no known absolute contraindications to the use of allergenic extracts for immunotherapy. immunotherapy with specific antigens should not be done in those individuals who do not exhibit skin test or clinical sens

União Europeia - inglês - EMA (European Medicines Agency)

sanofi b.v. - agalsidase beta - fabry disease - other alimentary tract and metabolism products, - fabrazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease (α-galactosidase-a deficiency).

Estados Unidos - inglês - NLM (National Library of Medicine)

allergy laboratories, inc. - apple (unii: b423vgh5s9) (apple - unii:b423vgh5s9) - apple 1 g in 20 ml - immunotherapy using allergenic extracts is indicated for use in patients with severe allergy symptoms (hay fever, rhinitis, etc.) to pollens, molds, insects, animal danders and various other allergens. immunotherapy is intended for patients whose symptoms are not satisfactorily controlled by avoidance of the offending allergen or by the use of symptomatic medications. treatment uses only those specific allergens that the patient is sensitive to based on diagnostic tests and medical history. it is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no known absolute contraindications to diagnostic testing or hyposensitization with allergen immunotherapy.  patients with cardiovascular disease or pulmonary disease such as symptomatic asthma, and/or who are receiving cardiovascular drugs such as beta blockers, may be at higher risk for severe adverse reactions. these patients may also be more refractory to the

União Europeia - inglês - EMA (European Medicines Agency)

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry disease - other alimentary tract and metabolism products, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

União Europeia - inglês - EMA (European Medicines Agency)

amicus therapeutics europe limited - migalastat hydrochloride - fabry disease - migalastat - galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of fabry disease (α-galactosidase a deficiency) and who have an amenable mutation.

União Europeia - inglês - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - agalsidase alfa - fabry disease - other alimentary tract and metabolism products, - replagal is indicated for long-term enzyme-replacement therapy in patients with a confirmed diagnosis of fabry disease (α-galactosidase-a deficiency).

Canadá - inglês - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - agalsidase beta - powder for solution - 5mg - agalsidase beta 5mg - enzymes

Canadá - inglês - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - agalsidase beta - powder for solution - 35mg - agalsidase beta 35mg - enzymes

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48) - aspergillus fumigatus 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t